Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Ivor Douglas

Concepts (602)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Respiration, Artificial
24
2025
645
3.730
 Why?
Sepsis
23
2025
617
3.240
 Why?
Fluid Therapy
14
2025
147
2.860
 Why?
Respiratory Insufficiency
12
2023
318
2.310
 Why?
Critical Care
19
2025
601
2.190
 Why?
Critical Illness
20
2025
811
2.040
 Why?
Intensive Care Units
24
2025
827
1.960
 Why?
Tracheostomy
5
2024
133
1.730
 Why?
Shock, Septic
11
2024
219
1.550
 Why?
Hospital Mortality
19
2024
911
1.490
 Why?
Hypotension
6
2025
122
1.450
 Why?
Shock
3
2024
98
1.420
 Why?
Resuscitation
11
2025
251
1.370
 Why?
Vasoconstrictor Agents
7
2025
139
1.290
 Why?
Hospitals
6
2023
691
1.250
 Why?
Pneumonia
7
2023
639
1.120
 Why?
Resuscitation Orders
3
2023
44
1.000
 Why?
Multiple Organ Failure
4
2024
128
0.950
 Why?
Humans
138
2025
137585
0.860
 Why?
Patient Readmission
6
2021
697
0.850
 Why?
Ultrasonography, Doppler
1
2024
124
0.820
 Why?
Middle Aged
61
2025
33479
0.820
 Why?
Aged
48
2025
23961
0.810
 Why?
Pneumonia, Ventilator-Associated
2
2015
53
0.790
 Why?
Safety-net Providers
3
2023
119
0.740
 Why?
Hospitals, High-Volume
2
2019
44
0.730
 Why?
Hemodynamics
3
2024
1113
0.720
 Why?
Severity of Illness Index
6
2021
2828
0.700
 Why?
Monitoring, Physiologic
4
2024
275
0.700
 Why?
Extracorporeal Membrane Oxygenation
2
2023
301
0.690
 Why?
Male
76
2025
67762
0.680
 Why?
Patient Acceptance of Health Care
5
2021
806
0.670
 Why?
Frailty
1
2023
170
0.670
 Why?
Patient Positioning
1
2021
67
0.670
 Why?
Retrospective Studies
31
2025
15657
0.670
 Why?
Diabetes Insipidus
1
2020
6
0.670
 Why?
Practice Guidelines as Topic
6
2021
1587
0.630
 Why?
Substance Withdrawal Syndrome
3
2021
179
0.620
 Why?
Hospitals, Low-Volume
1
2019
22
0.610
 Why?
Noninvasive Ventilation
4
2025
51
0.590
 Why?
Female
67
2025
73304
0.580
 Why?
Dyspnea
2
2021
254
0.570
 Why?
Acute Kidney Injury
8
2025
815
0.570
 Why?
Delirium
3
2025
92
0.540
 Why?
Adult
44
2025
37929
0.540
 Why?
Pulmonary Disease, Chronic Obstructive
8
2025
1040
0.530
 Why?
Diabetes Mellitus
2
2020
1040
0.530
 Why?
Ventilator-Induced Lung Injury
3
2018
59
0.520
 Why?
Alcoholism
5
2021
807
0.520
 Why?
Pulmonary Medicine
3
2015
85
0.510
 Why?
California
5
2022
431
0.510
 Why?
Microbiological Techniques
1
2016
30
0.500
 Why?
Sleep Medicine Specialty
1
2015
11
0.490
 Why?
Acute Lung Injury
6
2023
287
0.480
 Why?
Molecular Diagnostic Techniques
1
2016
105
0.470
 Why?
Neoplasms
3
2023
2671
0.460
 Why?
Hyperemia
3
2024
49
0.460
 Why?
Health Policy
4
2024
388
0.460
 Why?
Ethanol
2
2021
608
0.450
 Why?
Randomized Controlled Trials as Topic
10
2023
1477
0.440
 Why?
Research Design
9
2023
1139
0.420
 Why?
Aged, 80 and over
13
2025
7635
0.420
 Why?
Renin-Angiotensin System
2
2025
85
0.420
 Why?
Prone Position
3
2021
30
0.410
 Why?
Cohort Studies
11
2023
5742
0.410
 Why?
Receptor, EphA2
3
2018
19
0.410
 Why?
Bronchoalveolar Lavage Fluid
2
2016
652
0.400
 Why?
Cause of Death
3
2015
434
0.390
 Why?
Immune Tolerance
1
2015
363
0.390
 Why?
Laryngoscopes
2
2023
38
0.390
 Why?
Inpatients
3
2023
500
0.390
 Why?
Nicotinic Agonists
1
2014
129
0.390
 Why?
Dual Specificity Phosphatase 1
1
2012
26
0.390
 Why?
Marijuana Smoking
1
2015
252
0.380
 Why?
Cross Infection
5
2020
256
0.370
 Why?
Hospitalization
10
2025
2199
0.370
 Why?
Apoptosis
6
2014
2553
0.360
 Why?
Tobacco Use Disorder
1
2014
251
0.360
 Why?
Lung
12
2018
4060
0.360
 Why?
Prospective Studies
13
2025
7604
0.360
 Why?
Nicotine
1
2014
334
0.350
 Why?
Tissue Plasminogen Activator
2
2024
224
0.350
 Why?
Organ Dysfunction Scores
2
2024
48
0.350
 Why?
Lipopolysaccharides
4
2017
886
0.350
 Why?
Pulmonary Fibrosis
4
2017
402
0.350
 Why?
Immunity, Innate
1
2017
828
0.350
 Why?
Glycosaminoglycans
3
2016
83
0.340
 Why?
Protein C
5
2012
59
0.340
 Why?
Drug Delivery Systems
1
2014
365
0.340
 Why?
Glycocalyx
2
2025
27
0.330
 Why?
Child Development
1
2015
475
0.330
 Why?
Long-Term Care
2
2022
107
0.330
 Why?
Treatment Outcome
16
2025
10811
0.320
 Why?
Smoking Cessation
1
2014
442
0.320
 Why?
Antipsychotic Agents
2
2024
194
0.320
 Why?
Emergency Service, Hospital
5
2024
2069
0.310
 Why?
Vena Cava, Inferior
3
2024
71
0.310
 Why?
Ephrin-A1
3
2018
4
0.310
 Why?
Comorbidity
4
2022
1622
0.310
 Why?
Biomarkers
8
2025
4149
0.300
 Why?
Metabolic Syndrome
2
2023
354
0.300
 Why?
Length of Stay
6
2024
1215
0.300
 Why?
United States
18
2024
14841
0.300
 Why?
Public Health
1
2014
588
0.300
 Why?
Lipid A
2
2014
29
0.300
 Why?
Institutional Practice
1
2008
4
0.290
 Why?
Cannabis
1
2015
494
0.290
 Why?
Intubation, Intratracheal
4
2024
257
0.290
 Why?
Societies, Medical
7
2021
820
0.280
 Why?
Odds Ratio
6
2019
1070
0.280
 Why?
Personnel Staffing and Scheduling
1
2008
96
0.280
 Why?
Betacoronavirus
2
2020
270
0.280
 Why?
Neutrophils
3
2024
1238
0.270
 Why?
Pandemics
4
2024
1639
0.270
 Why?
Pulmonary Alveolar Proteinosis
1
2007
17
0.260
 Why?
Integrins
1
2007
95
0.260
 Why?
Neovascularization, Pathologic
2
2007
301
0.260
 Why?
Haloperidol
3
2025
34
0.260
 Why?
Anti-Bacterial Agents
1
2017
1809
0.260
 Why?
MAP Kinase Signaling System
2
2014
320
0.250
 Why?
Hyponatremia
1
2006
42
0.250
 Why?
Patient Admission
2
2023
197
0.250
 Why?
Lung Diseases, Obstructive
1
2006
50
0.250
 Why?
Lung Injury
3
2016
219
0.250
 Why?
Leukocytes
1
2007
311
0.250
 Why?
Ultrasonography
3
2024
759
0.240
 Why?
Renal Insufficiency, Chronic
2
2024
617
0.240
 Why?
Double-Blind Method
9
2024
1993
0.240
 Why?
Pneumonia, Viral
2
2020
373
0.240
 Why?
Medicaid
3
2021
435
0.240
 Why?
Coronavirus Infections
2
2020
364
0.240
 Why?
Laryngoscopy
2
2023
109
0.240
 Why?
Chemokines, CXC
1
2005
70
0.230
 Why?
Bronchi
1
2006
260
0.230
 Why?
Academic Medical Centers
3
2021
512
0.230
 Why?
Biomedical Research
3
2021
692
0.230
 Why?
Bronchiectasis
1
2006
111
0.230
 Why?
Oxazines
1
2024
30
0.230
 Why?
Bronchiolitis Obliterans
1
2005
69
0.230
 Why?
Adrenal Insufficiency
2
2013
31
0.230
 Why?
Infusions, Intravenous
5
2024
413
0.230
 Why?
Regeneration
1
2006
197
0.220
 Why?
Methylprednisolone
1
2005
86
0.220
 Why?
Venous Pressure
1
2024
8
0.220
 Why?
Patient Protection and Affordable Care Act
2
2016
103
0.220
 Why?
Plasminogen
1
2024
30
0.220
 Why?
Catheterization, Peripheral
1
2025
109
0.220
 Why?
Phagocytosis
1
2006
380
0.220
 Why?
Morpholines
1
2024
122
0.220
 Why?
Leukocyte Elastase
1
2024
76
0.220
 Why?
Vasopressins
3
2021
64
0.210
 Why?
Plasminogen Activator Inhibitor 1
1
2024
86
0.210
 Why?
Respiratory Mucosa
1
2006
321
0.210
 Why?
Anti-Infective Agents
4
2012
255
0.210
 Why?
Cytokines
7
2017
2085
0.210
 Why?
Atrial Pressure
1
2023
3
0.210
 Why?
Renal Dialysis
4
2023
435
0.210
 Why?
beta Catenin
1
2005
253
0.210
 Why?
Hypoxia
3
2024
1112
0.210
 Why?
Receptor, Angiotensin, Type 1
1
2023
25
0.210
 Why?
Diterpenes
2
2014
31
0.210
 Why?
Area Under Curve
3
2020
314
0.200
 Why?
Analgesics, Non-Narcotic
1
2024
125
0.200
 Why?
Hemodynamic Monitoring
1
2022
1
0.200
 Why?
Risk Factors
10
2021
10388
0.200
 Why?
Lung Diseases
3
2016
767
0.200
 Why?
Thiazoles
2
2024
123
0.200
 Why?
Craniocerebral Trauma
1
2005
170
0.200
 Why?
Fibrinolysis
1
2024
146
0.200
 Why?
Fibrosis
1
2005
552
0.190
 Why?
Treatment Failure
6
2021
356
0.190
 Why?
Early Diagnosis
4
2017
242
0.180
 Why?
Evidence-Based Medicine
5
2016
740
0.180
 Why?
Transportation
1
2022
53
0.180
 Why?
Acetaminophen
1
2024
268
0.180
 Why?
Clinical Decision-Making
1
2024
322
0.180
 Why?
Central Nervous System Depressants
1
2021
85
0.180
 Why?
Vasodilator Agents
1
2023
331
0.180
 Why?
Logistic Models
7
2017
2074
0.170
 Why?
Receptors, Interleukin-6
1
2021
43
0.170
 Why?
Hydrocortisone
1
2003
322
0.170
 Why?
Pyridines
1
2024
506
0.170
 Why?
Heart Arrest
2
2021
339
0.170
 Why?
Hospital Charges
1
2020
44
0.170
 Why?
Stroke Volume
1
2024
612
0.170
 Why?
Piperazines
2
2024
350
0.170
 Why?
Hydroxychloroquine
1
2020
58
0.170
 Why?
Rib Fractures
1
2020
32
0.170
 Why?
Health Priorities
1
2020
44
0.170
 Why?
Glucocorticoids
1
2005
594
0.170
 Why?
Antigens, Differentiation
1
2000
83
0.160
 Why?
Community-Acquired Infections
3
2020
174
0.160
 Why?
Endothelium, Vascular
2
2025
927
0.160
 Why?
Reproducibility of Results
5
2024
3284
0.160
 Why?
Internship and Residency
2
2019
1147
0.160
 Why?
Heart Failure
3
2023
2236
0.160
 Why?
Cell Proliferation
2
2014
2475
0.160
 Why?
Patient Handoff
1
2019
32
0.160
 Why?
Risk Adjustment
1
2020
78
0.160
 Why?
Animals
20
2018
36940
0.160
 Why?
Patient Selection
1
2023
696
0.160
 Why?
Cell Adhesion Molecules
1
2000
181
0.150
 Why?
Hospital Costs
1
2019
117
0.150
 Why?
Dopamine Antagonists
1
2018
27
0.150
 Why?
Combined Modality Therapy
2
2020
1236
0.150
 Why?
Age Factors
4
2019
3295
0.150
 Why?
Mice, Inbred C57BL
9
2018
5757
0.150
 Why?
Orthopedic Procedures
1
2020
216
0.140
 Why?
ROC Curve
1
2020
554
0.140
 Why?
Blood Glucose Self-Monitoring
1
2023
641
0.140
 Why?
Antimicrobial Stewardship
1
2020
118
0.140
 Why?
Thrombosis
1
2021
371
0.140
 Why?
Optometry
1
2017
8
0.140
 Why?
Platelet Count
2
2014
86
0.140
 Why?
Eosinophils
1
2000
332
0.140
 Why?
Tidal Volume
2
2014
86
0.130
 Why?
Cell Adhesion
4
2012
466
0.130
 Why?
Caregivers
1
2025
877
0.130
 Why?
Predictive Value of Tests
4
2016
2031
0.130
 Why?
Guideline Adherence
2
2014
556
0.130
 Why?
Health Services Accessibility
4
2020
986
0.130
 Why?
Lymphocyte Count
1
2017
148
0.130
 Why?
Transients and Migrants
1
2017
24
0.130
 Why?
Analysis of Variance
1
2020
1316
0.130
 Why?
Blood Glucose
2
2023
2186
0.130
 Why?
Pyrimidines
2
2024
470
0.130
 Why?
Tretinoin
1
2017
123
0.130
 Why?
Nephrectomy
2
2008
169
0.130
 Why?
Health Insurance Exchanges
1
2016
1
0.130
 Why?
Risk Management
1
2017
93
0.130
 Why?
Continuity of Patient Care
1
2018
284
0.130
 Why?
Cystic Fibrosis
1
2006
1114
0.130
 Why?
Mice
13
2017
17787
0.120
 Why?
Delivery of Health Care
1
2023
951
0.120
 Why?
Ventricular Function, Right
1
2018
285
0.120
 Why?
Clinical Trials as Topic
1
2021
1050
0.120
 Why?
Breath Tests
1
2016
87
0.120
 Why?
Sleep Wake Disorders
2
2017
286
0.120
 Why?
Attitude of Health Personnel
3
2019
1171
0.120
 Why?
Ventricular Dysfunction, Right
1
2018
238
0.120
 Why?
Antibodies, Monoclonal, Humanized
1
2021
804
0.120
 Why?
Respiratory Tract Diseases
1
2017
184
0.120
 Why?
Burnout, Professional
1
2021
442
0.120
 Why?
Research
1
2018
451
0.120
 Why?
Alcohol Withdrawal Seizures
1
2014
1
0.110
 Why?
Survival Analysis
4
2014
1325
0.110
 Why?
Alcohol Withdrawal Delirium
1
2014
8
0.110
 Why?
Bronchoalveolar Lavage
1
2015
93
0.110
 Why?
Staphylococcus aureus
2
2011
450
0.110
 Why?
Automation
1
2015
95
0.110
 Why?
Marriage
1
2016
121
0.110
 Why?
5-Lipoxygenase-Activating Protein Inhibitors
1
2014
1
0.110
 Why?
5-Lipoxygenase-Activating Proteins
1
2014
4
0.110
 Why?
Bacteriological Techniques
1
2015
73
0.110
 Why?
Heparitin Sulfate
3
2025
50
0.110
 Why?
Leukotrienes
1
2014
37
0.110
 Why?
Fluorobenzenes
1
2014
16
0.110
 Why?
Multicenter Studies as Topic
3
2023
310
0.110
 Why?
Prognosis
5
2021
4030
0.110
 Why?
Patient Care Team
1
2019
631
0.110
 Why?
Phenanthrenes
1
2014
13
0.110
 Why?
Risk Assessment
5
2015
3457
0.110
 Why?
APACHE
2
2011
69
0.110
 Why?
Potassium
1
2014
147
0.110
 Why?
Physicians
2
2021
910
0.110
 Why?
Down-Regulation
2
2017
657
0.110
 Why?
Education, Medical
1
2017
266
0.110
 Why?
Alanine Transaminase
1
2014
157
0.110
 Why?
Catheterization, Central Venous
1
2015
112
0.110
 Why?
Quality of Life
2
2024
2892
0.110
 Why?
Poverty
2
2016
521
0.110
 Why?
Systemic Inflammatory Response Syndrome
1
2014
93
0.110
 Why?
Kaplan-Meier Estimate
5
2018
889
0.110
 Why?
CD4-Positive T-Lymphocytes
1
2000
1091
0.100
 Why?
Laryngeal Masks
1
2013
14
0.100
 Why?
Microscopy
1
2015
152
0.100
 Why?
Quinolines
1
2014
178
0.100
 Why?
Health Knowledge, Attitudes, Practice
2
2024
1329
0.100
 Why?
Time Factors
7
2023
6828
0.100
 Why?
Physician-Patient Relations
1
2017
548
0.100
 Why?
Supine Position
1
2012
39
0.090
 Why?
Patient Discharge
1
2018
897
0.090
 Why?
Sensitivity and Specificity
2
2015
1946
0.090
 Why?
Patient-Centered Care
1
2017
530
0.090
 Why?
Acute Disease
3
2016
1007
0.090
 Why?
Biomarkers, Pharmacological
1
2012
28
0.090
 Why?
Cisplatin
1
2014
320
0.090
 Why?
Oxygen
3
2023
931
0.090
 Why?
I-kappa B Proteins
1
2012
81
0.090
 Why?
Clinical Alarms
1
2011
10
0.090
 Why?
Data Interpretation, Statistical
2
2011
363
0.090
 Why?
Insurance, Health
1
2014
283
0.090
 Why?
Data Display
1
2011
21
0.090
 Why?
Endotoxemia
1
2012
86
0.090
 Why?
Health Status
1
2017
792
0.090
 Why?
Follow-Up Studies
5
2024
5131
0.090
 Why?
Adrenergic beta-2 Receptor Agonists
1
2011
37
0.090
 Why?
Albuterol
1
2011
110
0.090
 Why?
Indoles
1
2014
412
0.090
 Why?
Genetic Markers
1
2012
344
0.090
 Why?
Sulfonamides
1
2014
513
0.080
 Why?
Fibrinolytic Agents
2
2024
270
0.080
 Why?
Peroxidase
2
2008
175
0.080
 Why?
Alcohol-Related Disorders
1
2011
122
0.080
 Why?
Stenotrophomonas maltophilia
1
2009
2
0.080
 Why?
Recombinant Proteins
5
2012
1353
0.080
 Why?
Thoracic Diseases
1
2009
14
0.080
 Why?
Interferons
1
2011
202
0.080
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
445
0.080
 Why?
Clinical Protocols
2
2012
271
0.080
 Why?
Decision Making
1
2017
900
0.080
 Why?
Symptom Assessment
2
2020
128
0.080
 Why?
Gram-Negative Bacterial Infections
1
2009
46
0.080
 Why?
Survival Rate
3
2015
1972
0.080
 Why?
Blotting, Western
1
2012
1226
0.080
 Why?
Ligands
2
2023
664
0.080
 Why?
Cell Movement
3
2011
967
0.080
 Why?
Wounds and Injuries
1
2016
758
0.080
 Why?
Adrenal Cortex Hormones
1
2013
565
0.080
 Why?
Up-Regulation
1
2012
843
0.080
 Why?
Confidence Intervals
1
2010
329
0.080
 Why?
Polymerase Chain Reaction
1
2012
1062
0.080
 Why?
Cues
1
2011
314
0.080
 Why?
Age Distribution
1
2010
392
0.080
 Why?
Databases, Factual
2
2016
1357
0.080
 Why?
Sex Distribution
1
2010
375
0.080
 Why?
Disease Models, Animal
5
2018
4295
0.080
 Why?
Pneumonia, Bacterial
1
2009
116
0.070
 Why?
Pancreatitis
1
2009
134
0.070
 Why?
Pulmonary Alveoli
2
2012
405
0.070
 Why?
Work Schedule Tolerance
1
2008
49
0.070
 Why?
Clinical Trials, Phase III as Topic
2
2023
106
0.070
 Why?
Models, Statistical
1
2012
669
0.070
 Why?
Incidence
1
2014
2804
0.070
 Why?
Healthcare Disparities
1
2014
654
0.070
 Why?
United Kingdom
1
2008
318
0.070
 Why?
Mandatory Programs
1
2007
15
0.070
 Why?
Pulmonary Emphysema
2
2007
288
0.070
 Why?
Demeclocycline
1
2006
2
0.070
 Why?
Interleukin-6
2
2008
778
0.070
 Why?
Mice, Inbred C3H
1
2007
269
0.070
 Why?
Flavonoids
1
2007
85
0.070
 Why?
Methicillin Resistance
1
2006
18
0.070
 Why?
Lithium Compounds
1
2006
12
0.070
 Why?
Child, Preschool
2
2015
11074
0.060
 Why?
Disease Progression
4
2017
2757
0.060
 Why?
Mitogen-Activated Protein Kinase 3
1
2007
152
0.060
 Why?
Signal Transduction
4
2018
5079
0.060
 Why?
Workload
1
2008
167
0.060
 Why?
Rats, Sprague-Dawley
1
2012
2486
0.060
 Why?
Carcinoma, Non-Small-Cell Lung
1
1995
1081
0.060
 Why?
Mitogen-Activated Protein Kinase 1
1
2007
185
0.060
 Why?
Intercellular Adhesion Molecule-1
2
2012
139
0.060
 Why?
Clinical Competence
1
2014
1118
0.060
 Why?
Receptors, Antigen, T-Cell, gamma-delta
1
2006
101
0.060
 Why?
Diuretics
1
2006
74
0.060
 Why?
Hospitals, Urban
2
2018
134
0.060
 Why?
Hospital Information Systems
1
2006
16
0.060
 Why?
Mesoderm
1
2007
144
0.060
 Why?
History, 20th Century
2
2017
325
0.060
 Why?
Sex Factors
3
2018
2071
0.060
 Why?
Radiography, Thoracic
1
2007
167
0.060
 Why?
Butylated Hydroxytoluene
1
2005
38
0.060
 Why?
Asparagine
1
2005
31
0.060
 Why?
Vocabulary
1
2006
38
0.060
 Why?
Angiopoietin-2
1
2025
16
0.060
 Why?
Mice, Inbred BALB C
2
2005
1272
0.060
 Why?
Emphysema
1
2006
106
0.060
 Why?
Bronchoscopy
1
2007
223
0.060
 Why?
Syndecan-1
1
2025
38
0.060
 Why?
Cyclin D1
1
2005
68
0.060
 Why?
Heparin
1
2007
261
0.060
 Why?
Protein Kinase Inhibitors
2
2024
916
0.060
 Why?
Rats
2
2012
5647
0.060
 Why?
Cell Line, Transformed
1
2005
145
0.060
 Why?
Medical Order Entry Systems
1
2006
43
0.060
 Why?
Caspase Inhibitors
1
2005
81
0.060
 Why?
Adolescent
5
2025
21513
0.060
 Why?
Blood Vessels
1
2007
187
0.060
 Why?
Hypertension, Pulmonary
2
2007
1910
0.060
 Why?
Occupational Health
1
2008
200
0.060
 Why?
Gene Expression Regulation
2
2012
2607
0.060
 Why?
Angiotensin I
1
2025
7
0.060
 Why?
Young Adult
5
2025
13209
0.060
 Why?
Venous Thrombosis
1
2007
190
0.060
 Why?
Ischemia
1
2008
409
0.060
 Why?
Gene Expression Profiling
1
2012
1774
0.060
 Why?
Neuromuscular Nondepolarizing Agents
1
2024
17
0.060
 Why?
Necrosis
1
2005
246
0.060
 Why?
Androstanols
1
2024
18
0.060
 Why?
HMGB1 Protein
1
2005
50
0.060
 Why?
Caspases
1
2005
247
0.060
 Why?
Hope
1
2024
22
0.060
 Why?
Pyridazines
1
2024
56
0.060
 Why?
Macrophages
2
2014
1547
0.050
 Why?
Medicago
1
2023
1
0.050
 Why?
Diabetic Ketoacidosis
1
2007
201
0.050
 Why?
T-Lymphocyte Subsets
1
2006
417
0.050
 Why?
Colorado
4
2017
4565
0.050
 Why?
Cadherins
1
2005
206
0.050
 Why?
Renal Replacement Therapy
1
2024
92
0.050
 Why?
Steroids
2
2021
167
0.050
 Why?
Uncertainty
1
2024
128
0.050
 Why?
Practice Patterns, Physicians'
3
2024
1313
0.050
 Why?
Enzyme Inhibitors
1
2007
840
0.050
 Why?
Atrial Function, Right
1
2023
12
0.050
 Why?
Angiotensins
1
2023
9
0.050
 Why?
Multivariate Analysis
2
2017
1509
0.050
 Why?
Collagen
1
2005
452
0.050
 Why?
Drug Administration Schedule
2
2018
786
0.050
 Why?
Biopsy
1
2007
1129
0.050
 Why?
Mental Health
2
2022
726
0.050
 Why?
Inflammatory Bowel Diseases
1
2007
351
0.050
 Why?
Homeostasis
1
2006
621
0.050
 Why?
Angiotensin II
1
2023
99
0.050
 Why?
Antineoplastic Agents
1
2014
2129
0.050
 Why?
Decision Support Techniques
2
2020
421
0.050
 Why?
Autoimmune Diseases
1
2006
460
0.050
 Why?
Diagnosis, Differential
1
2007
1483
0.050
 Why?
Video Recording
1
2023
180
0.050
 Why?
Anticoagulants
1
2007
664
0.050
 Why?
Hemoglobins
1
2024
353
0.050
 Why?
Staphylococcal Infections
1
2006
400
0.050
 Why?
Lung Neoplasms
1
1995
2526
0.050
 Why?
p38 Mitogen-Activated Protein Kinases
2
2014
283
0.050
 Why?
Partial Thromboplastin Time
1
2021
57
0.050
 Why?
Creatinine
2
2015
499
0.050
 Why?
Child
2
2015
21935
0.050
 Why?
Endothelial Cells
1
2007
785
0.050
 Why?
Oligopeptides
1
2023
271
0.040
 Why?
Infant
1
2015
9465
0.040
 Why?
Electrocardiography
1
2024
629
0.040
 Why?
Antibodies
2
2018
410
0.040
 Why?
Peptide Fragments
1
2025
706
0.040
 Why?
Perioperative Care
1
2022
178
0.040
 Why?
Lung Diseases, Interstitial
1
2007
638
0.040
 Why?
Leukotriene C4
1
2000
11
0.040
 Why?
CD18 Antigens
1
2000
26
0.040
 Why?
N-Formylmethionine Leucyl-Phenylalanine
1
2000
54
0.040
 Why?
CD11 Antigens
1
2000
30
0.040
 Why?
Drug Resistance, Microbial
1
2020
71
0.040
 Why?
Hemorrhage
1
2005
722
0.040
 Why?
Chronic Disease
1
2006
1793
0.040
 Why?
Glasgow Coma Scale
1
2020
186
0.040
 Why?
Costs and Cost Analysis
1
2020
213
0.040
 Why?
Hospitals, University
1
2019
182
0.040
 Why?
Epithelial Cells
1
2005
1096
0.040
 Why?
Aftercare
1
2001
208
0.040
 Why?
Flow Cytometry
2
2017
1178
0.040
 Why?
Needs Assessment
1
2021
376
0.040
 Why?
NF-kappa B
2
2018
691
0.040
 Why?
Oxidative Stress
1
2005
1317
0.040
 Why?
Smoking
1
2006
1627
0.040
 Why?
Algorithms
1
2006
1704
0.040
 Why?
Adjuvants, Immunologic
1
2000
226
0.040
 Why?
Surveys and Questionnaires
3
2021
5778
0.040
 Why?
Injury Severity Score
1
2020
522
0.040
 Why?
Infection Control
1
2020
167
0.040
 Why?
Class Ib Phosphatidylinositol 3-Kinase
1
2018
4
0.040
 Why?
Linear Models
1
2020
849
0.040
 Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2018
35
0.040
 Why?
Trauma Centers
1
2020
421
0.040
 Why?
Mice, Knockout
3
2012
3015
0.040
 Why?
T-Lymphocytes
1
2006
1996
0.040
 Why?
Victoria
1
2017
18
0.030
 Why?
History, 17th Century
1
2017
16
0.030
 Why?
History, 15th Century
1
2017
12
0.030
 Why?
History, 16th Century
1
2017
16
0.030
 Why?
Family
1
2022
671
0.030
 Why?
United Arab Emirates
1
2017
7
0.030
 Why?
History, Ancient
1
2017
54
0.030
 Why?
History, Medieval
1
2017
47
0.030
 Why?
Mortality
1
2019
362
0.030
 Why?
Antigens, CD
1
2000
521
0.030
 Why?
Critical Care Outcomes
1
2016
12
0.030
 Why?
Recovery of Function
1
2021
653
0.030
 Why?
Drug Therapy, Combination
2
2012
1066
0.030
 Why?
Phenotype
1
2025
3196
0.030
 Why?
Stress Disorders, Post-Traumatic
1
2025
847
0.030
 Why?
History, 21st Century
1
2017
213
0.030
 Why?
Trauma Severity Indices
1
2016
106
0.030
 Why?
Probability
1
2017
304
0.030
 Why?
Cross-Sectional Studies
2
2021
5472
0.030
 Why?
Lymphocyte Activation
1
2000
1142
0.030
 Why?
Refugees
1
2017
75
0.030
 Why?
Proto-Oncogene Proteins c-akt
1
2018
437
0.030
 Why?
Uteroglobin
1
2014
23
0.030
 Why?
Chemokine CXCL2
1
2014
43
0.030
 Why?
Cost-Benefit Analysis
1
2017
591
0.030
 Why?
Arachidonate 5-Lipoxygenase
1
2014
43
0.030
 Why?
Rosuvastatin Calcium
1
2014
22
0.030
 Why?
Nitrites
1
2014
84
0.030
 Why?
Anxiety
1
2022
1035
0.030
 Why?
MAP Kinase Kinase 4
1
2014
29
0.030
 Why?
Risk
1
2017
912
0.030
 Why?
Epoxy Compounds
1
2014
33
0.030
 Why?
Pilot Projects
1
2019
1710
0.030
 Why?
Creatine Kinase
1
2014
79
0.030
 Why?
Nitrates
1
2014
92
0.030
 Why?
Quality Indicators, Health Care
1
2017
307
0.030
 Why?
Socioeconomic Factors
1
2018
1289
0.030
 Why?
Chondroitin Sulfates
1
2014
32
0.030
 Why?
Leukocyte Count
1
2014
329
0.030
 Why?
Kidney Function Tests
1
2014
160
0.030
 Why?
Toll-Like Receptor 2
1
2014
115
0.030
 Why?
Manikins
1
2013
29
0.030
 Why?
Liver Failure
1
2014
94
0.030
 Why?
Bronchial Spasm
1
2013
6
0.030
 Why?
Cryptogenic Organizing Pneumonia
1
2013
19
0.030
 Why?
Contraindications
1
2013
90
0.030
 Why?
Chromatography, Liquid
1
2015
433
0.030
 Why?
Mass Spectrometry
1
2016
739
0.020
 Why?
Quality Improvement
1
2021
1178
0.020
 Why?
Glucuronidase
1
2012
44
0.020
 Why?
Depression
1
2022
1397
0.020
 Why?
Protein C Deficiency
1
2012
12
0.020
 Why?
Connective Tissue Diseases
1
2013
84
0.020
 Why?
Receptors, Tumor Necrosis Factor, Type I
1
2012
87
0.020
 Why?
Knowledge Bases
1
2012
27
0.020
 Why?
Intestinal Perforation
1
2012
46
0.020
 Why?
Cells, Cultured
1
2000
4193
0.020
 Why?
Toll-Like Receptor 4
1
2014
273
0.020
 Why?
Tandem Mass Spectrometry
1
2015
532
0.020
 Why?
Renal Insufficiency
1
2014
162
0.020
 Why?
Triage
1
2014
222
0.020
 Why?
Quality Assurance, Health Care
1
2014
322
0.020
 Why?
Endothelium
1
2012
123
0.020
 Why?
Water-Electrolyte Balance
1
2011
34
0.020
 Why?
Anesthesiology
1
2013
87
0.020
 Why?
Quality of Health Care
1
2017
642
0.020
 Why?
Adoptive Transfer
1
2012
219
0.020
 Why?
Epistasis, Genetic
1
2012
70
0.020
 Why?
Disease Management
1
2016
628
0.020
 Why?
Cross-Over Studies
1
2013
564
0.020
 Why?
Cell Survival
1
2014
1120
0.020
 Why?
General Surgery
1
2013
173
0.020
 Why?
Microbial Viability
1
2011
91
0.020
 Why?
Superoxides
1
2011
202
0.020
 Why?
Enzyme Activation
1
2012
810
0.020
 Why?
Internal Medicine
1
2013
265
0.020
 Why?
Interleukin-8
1
2011
268
0.020
 Why?
Cell Separation
1
2011
318
0.020
 Why?
Single-Payer System
1
2009
2
0.020
 Why?
Viruses
1
2011
113
0.020
 Why?
Species Specificity
1
2011
585
0.020
 Why?
Longitudinal Studies
1
2017
2844
0.020
 Why?
Disease-Free Survival
1
2011
686
0.020
 Why?
Administration, Inhalation
1
2011
688
0.020
 Why?
Cell Death
1
2011
374
0.020
 Why?
Survivors
1
2013
493
0.020
 Why?
Arthroplasty, Replacement, Knee
1
2014
363
0.020
 Why?
Nitric Oxide
1
2014
915
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2011
852
0.020
 Why?
Information Dissemination
1
2011
218
0.020
 Why?
Advisory Committees
1
2010
219
0.020
 Why?
Case-Control Studies
1
2016
3556
0.020
 Why?
Total Quality Management
1
2008
61
0.020
 Why?
Cell Line
1
2014
2847
0.020
 Why?
Self Report
1
2013
827
0.020
 Why?
Ventilator Weaning
1
2008
36
0.020
 Why?
Drug Resistance, Bacterial
1
2009
186
0.020
 Why?
Microbial Sensitivity Tests
1
2009
361
0.020
 Why?
Placebos
1
2008
199
0.020
 Why?
Neutrophil Infiltration
1
2008
107
0.020
 Why?
Precision Medicine
1
2012
429
0.020
 Why?
Capillary Permeability
1
2008
145
0.020
 Why?
United States Food and Drug Administration
1
2008
208
0.020
 Why?
Health Plan Implementation
1
2008
142
0.020
 Why?
Interdisciplinary Communication
1
2008
191
0.020
 Why?
Drug Industry
1
2008
111
0.020
 Why?
Chemokines
1
2008
228
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2012
1242
0.020
 Why?
Acid-Base Equilibrium
1
2007
28
0.020
 Why?
Dose-Response Relationship, Drug
1
2011
2057
0.020
 Why?
Cost Control
1
2006
39
0.020
 Why?
Umbilical Veins
1
2006
62
0.020
 Why?
Medical Audit
1
2007
78
0.020
 Why?
CD8 Antigens
1
2006
75
0.020
 Why?
Ketones
1
2007
49
0.020
 Why?
Microcirculation
1
2007
149
0.020
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2006
108
0.020
 Why?
CD4 Antigens
1
2006
141
0.020
 Why?
Bacillus subtilis
1
2006
66
0.020
 Why?
Information Management
1
2006
18
0.020
 Why?
Cell Count
1
2006
324
0.020
 Why?
Fluorescent Antibody Technique
1
2006
390
0.020
 Why?
Genome-Wide Association Study
1
2012
1431
0.010
 Why?
User-Computer Interface
1
2006
159
0.010
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2007
250
0.010
 Why?
Interleukin-10
1
2006
302
0.010
 Why?
Polymorphism, Single Nucleotide
1
2012
2189
0.010
 Why?
Inflammation Mediators
1
2006
513
0.010
 Why?
Asthma
1
2017
2295
0.010
 Why?
Hypoglycemia
1
2007
445
0.010
 Why?
Cardiotonic Agents
1
2001
124
0.010
 Why?
Hypothermia, Induced
1
2001
80
0.010
 Why?
RNA, Messenger
1
2006
2833
0.010
 Why?
Dopamine
1
2001
303
0.010
 Why?
Mass Screening
1
2006
1287
0.010
 Why?
Hypoglycemic Agents
1
2007
1291
0.010
 Why?
Anti-Inflammatory Agents
1
2001
496
0.010
 Why?
Insulin
1
2007
2409
0.010
 Why?
Douglas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (602) concept(s)
_
Co-Authors Expand Description
See all (79) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)